TP53 mutation-associated immune infiltration and a novel risk score model in HNSCC
Open Access
- 13 October 2022
- journal article
- research article
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 32, 101359
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- A p53-regulated immune checkpoint relevant to cancerScience, 2015
- TP53: an oncogene in disguiseCell Death & Differentiation, 2015
- Inferring tumour purity and stromal and immune cell admixture from expression dataNature Communications, 2013
- Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: Evidence from a systematic review and meta-analysisEuropean Journal of Cancer, 2012
- IsoLasso: A LASSO Regression Approach to RNA-Seq Based Transcriptome AssemblyJournal of Computational Biology, 2011
- Human NK Cells Are Alerted to Induction of p53 in Cancer Cells by Upregulation of the NKG2D Ligands ULBP1 and ULBP2Cancer Research, 2011
- p53, HER2 and tumor cell apoptosis correlate with clinical outcome after neoadjuvant bevacizumab plus chemotherapy in breast cancerInternational Journal of Oncology, 2011
- The Toll-Like Receptor Gene Family Is Integrated into Human DNA Damage and p53 NetworksPLOS Genetics, 2011
- TP53Mutations and Survival in Squamous-Cell Carcinoma of the Head and NeckNew England Journal of Medicine, 2007
- Integration of interferon-α/β signalling to p53 responses in tumour suppression and antiviral defenceNature, 2003